Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy
The in vivoanticancer efficacy of nanoparticle-mediated drug delivery depends on the association between the drug and its carrier. Here, the authors use FRET to show that the drug hydrophobicity, and miscibility with the carrier, influence nanoparticle accumulation in murine tumour models.
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2016
|
| Subjects: | |
| Online Access: | https://doaj.org/article/d90fceee65ae4c4ca9f5fa1e73acfa06 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|